- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04438161
Study to Understand Risk and Resilience Opportunity for Newborns After Delivery (SURROuND)
Identification of Newborns at High Risk for the Occurrence of Preventable Child Maltreatment: Phase 3 of Project 3 in the Overall Center for Innovation in Child Maltreatment Policy, Research, and Training (CICM), a Capstone Centers Grant.
Childhood Maltreatment (CM) has highly deleterious effects on human development and is a preventable known cause of enduring psychopathology in the United States. Infants and young children are at particularly high risk for physical harm from abuse and neglect, comprising over 60% of all child maltreatment fatalities. An increasing number of studies point to the ability to target prevention of CM by estimating individual specific risk at the time of birth, on the basis of readily-accessible data elements of birth records. This clinical trial is a randomized controlled trial embedded within a prospective longitudinal study, in which families of infants recruited prenatally or in the newborn period are randomized to an enhanced level of engagement in resource navigation, which we refer to as Personalized Education Regarding Clinical and Community Supports (PERCCS). The enhancement involves keying recommendations for evidence-informed interventions for the prevention of CM to established risk factors for ascertained within a family.
The parent longitudinal cohort study involves enrollment of a diverse population of families of newborns (prenatally or in the immediate postnatal period) for the purpose of ascertaining sociodemographic, psychological (eg. parental stress) and family psychiatric risk factors for (a) child maltreatment (b) unmet service needs, and (c) adverse behavioral outcomes of the children. Families are contacted quarterly to track acquisition of support services that are relevant to the prevention of child maltreatment. At age 18 months early childhood behavioral outcomes are ascertained, biomaterials collected, and official-report child maltreatment records from the State of Missouri are individually cross-matched with identifiers of the children and their parents.
Two major outcomes are examined:
The first is whether the engagement protocol results in a higher level of acquisition and active participation in recommended preventive intervention services by the families (including home visitation, parental mental health care, evidence-based parenting education, and others delineated in Table 1, see below).
The second is the rate of child maltreatment (CM) ascertained in official Missouri state administrative records for which individual informed consent to individually-cross reference is obtained by the families in the course of their enrollment in the parent longitudinal study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Sample: The sample will be recruited from the Washington University School of Medicine Obstetrical Service within the Barnes Jewish Christian (BJC) Health System, on which there are over 3000 Missouri childbirths per year, serving an urban population of families that are disproportionately affected by poverty. Fifty-five per cent of patients report a family income less than $20,000, 65% of the mothers are unemployed, and the majority of the newborns are on Medicaid or are Medicaid-eligible. In preliminary screening efforts, over one third of the mothers reported their own childhood histories of maltreatment, and approximately one half score in the clinical range for depressive symptomatology.
Methods: A schematic summarizing study enrollment, participant randomization, and ascertainment of outcomes is provided in Figure 1.
Study Approach and Design: N=400 families are in the process of being enrolled in the parent longitudinal study. Among those who fall in an elevated risk category (upper 50% of the sample for total count of established risk factors) we will randomize 150 families 2:1 to Personalized Education Regarding Clinical and Community Supports (PERCCS) versus Usual Care. Risk counts are calculated by the total number of established predictors of risk for CM (itemized in Table 1) ascertained from birth records and: i) a screen for maternal depression, ii) a screen for maternal childhood trauma, and iii) a screen for active intimate partner violence. Utilization of community-based evidence-informed support services will be ascertained at baseline and quarterly thereafter for all study participants. Official-report Child Maltreatment data from Missouri state administrative data will be individually linked with participant research records when the children reach 18 months of age.
PERCCS involves i) a review with the mother of all family CM risks ascertained in the context of their own individual screening ii) recommendations of community and clinical interventions which substantively respond to those risks and are available to the subject (on the basis of each individual subject's zip code, insurance, and eligibility for the interventions), collectively the personalized family resource plan, iii) facilitation of contact between the subject and the respective provider agencies to initiate enrollment; and iv) authorization for the research team to share the personalized risk profile and support recommendations with the infant's outpatient primary care provider.
The community and clinical supports responsive to specific risk factors are listed in Table 1, which summarizes the array of evidence-informed preventions that will be presented to the families, and the correspondence with each to specific CM risks ascertained within a family. Table 2 depicts the set of scripts which are used by the study team to standardize all aspects of the review of endorsed risks, their potential adverse effects on parenting, and the opportunities for mitigation through evidence-informed intervention.
All participants will receive care as usual, including the provision of a summary document itemizing key community supports for families of infants, a continuously-updated local community resource handbook, a published parenting guide, and opportunity to enroll free-of-charge in a virtual parenting education and developmental surveillance program, babynavigator.com.
Key Measures:
The Utilization of Community Services (UCS) is a survey that will be used to ascertain engagement of families in community supports and interventions, including tracking of both frequency and duration. This survey is completed at the time of study enrollment to establish a baseline, and quarterly thereafter until the completion of the study when a child reaches 18 months of age.
State Records: The second primary outcome, rate of child maltreatment, will rely on official state records from the State of Missouri Department of Social Services. Participants are aware that accessing service records or CM report data are retrospective when acquired and do not pose any risk or liability to them nor can it impact services received.
Statistical Analyses:
I. Intent-to-treat analysis of impact of PERCCS on service utilization. We will calculate the total proportion of evidence-informed services indicated by risk profiles of all families within each group (the intervention group and the control group) and compare the groups using chi square analysis.
II. Intent-to-treat analysis of the impact of PERCCS on the occurrence of child maltreatment. We will compare the rate of official-report abuse/neglect between the groups using chi square analysis.
III. (Secondary) We will conduct logistic regression analysis simultaneously examining the effects of risk count and service access on official report child maltreatment outcome.
The randomized controlled trial has adequate statistical power to detect an odds ratio of 2.0 for the effect of PERRCS in reducing child maltreatment outcome.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
St Louis, Missouri, United States, 63108
- Washington University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants will be Missouri residents
- 18 years of age or older
- Engaged in the BJC Healthcare Obstetrics or Newborn Services
Exclusion Criteria:
- Participants who are not Missouri residents
- Under the age of 18 years
- Not engaged in the BJC Healthcare Obstetrics or Newborn Services.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Low Risk
Low risk natural history study (n=250*) *Participants will be randomized 2:1 PERCCS:Control, and the randomization will be within successive sets of three families who fall in either "high risk" counts (n=105) families for child maltreatment or "low risk" counts (n=45) families. |
A brief follow-up to the screening provided to 50% of the consented families (randomly assigned) that links their specific familial risks to community interventions.
Other Names:
|
|
Experimental: High Risk
High risk families in prospective longitudinal study of newborns (n=150*). *Participants will be randomized 2:1 PERCCS:Control, and the randomization will be within successive sets of three families who fall in either "high risk" counts (n=105) families for child maltreatment or "low risk" counts (n=45) families. Participants in this arm will be randomized to:
|
A brief follow-up to the screening provided to 50% of the consented families (randomly assigned) that links their specific familial risks to community interventions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Service Utilization
Time Frame: Not more than 18 months postpartum
|
Proportion of evidence-informed services indicated by risk profiles of all families within group acquired over the course of follow-up.
|
Not more than 18 months postpartum
|
|
Child Maltreatment
Time Frame: Not more than 18 months postpartum
|
Rate of official reports of child maltreatment, ascertained from records of the Missouri Department of Social Services at age 18 months.
Child Maltreatment (number of cases of child abuse and neglect) as measured by official state administrative records
|
Not more than 18 months postpartum
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Mini Tandon, DO, Faculty
Publications and helpful links
General Publications
- Constantino JN. Child Maltreatment Prevention and the Scope of Child and Adolescent Psychiatry. Child Adolesc Psychiatr Clin N Am. 2016 Apr;25(2):157-65. doi: 10.1016/j.chc.2015.11.003. Epub 2016 Jan 11.
- Jaffee SR. Child Maltreatment and Risk for Psychopathology in Childhood and Adulthood. Annu Rev Clin Psychol. 2017 May 8;13:525-551. doi: 10.1146/annurev-clinpsy-032816-045005. Epub 2017 Mar 30.
- US DHHS, Children's Bureau (2017). Child Maltreatment 2015. Washington, DC: Author.U.S.
- Wu SS, Ma CX, Carter RL, Ariet M, Feaver EA, Resnick MB, Roth J. Risk factors for infant maltreatment: a population-based study. Child Abuse Negl. 2004 Dec;28(12):1253-64. doi: 10.1016/j.chiabu.2004.07.005.
- Putnam-Hornstein, E., & Needell, B. (2011). Predictors of child protective service contact between birth and age five: An examination of California's 2002 birth cohort. Children and Youth Services Review, 33(8), 1337-1344.
- Gilbert R, Widom CS, Browne K, Fergusson D, Webb E, Janson S. Burden and consequences of child maltreatment in high-income countries. Lancet. 2009 Jan 3;373(9657):68-81. doi: 10.1016/S0140-6736(08)61706-7. Epub 2008 Dec 4.
- Paulsell, D., Avellar, S., Sama Martin, E., & Del Grosso, P. Home Visiting Evidence of Effectiveness Review: Executive Summary. Office of Planning, Research and Evaluation, Administration for Children and Families, U.S. Department of Health and Human Services. 2011. Washington, DC.
- Jonson-Reid M, Kohl PL, Drake B. Child and adult outcomes of chronic child maltreatment. Pediatrics. 2012 May;129(5):839-45. doi: 10.1542/peds.2011-2529. Epub 2012 Apr 23.
- Tandon M, Jonson-Reid M, Constantino JN. Documenting Opportunity for Systematic Identification and Mitigation of Risk for Child Maltreatment. J Am Acad Child Adolesc Psychiatry. 2022 Nov;61(11):1313-1316. doi: 10.1016/j.jaac.2022.05.008. Epub 2022 Jun 8.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202007199
- 1P50HD096719 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on A. Longitudinal Cohort n=400
-
Instituto de Saude Publica da Universidade do PortoFinnish Institute for Health and Welfare; University of Tartu; Netherlands Organisation...UnknownControls | Participants of Longitudinal Cohort Studies
-
Dr. Wang Man-PingThe Hong Kong Jockey Club Charities TrustNot yet recruiting
-
New York Institute of TechnologyCompletedN/A Healthy IndividualsUnited States
-
Bristol-Myers SquibbPfizerCompleted
-
Bristol-Myers SquibbPfizerCompletedN/A - Healthy SubjectsUnited States
-
Biotie Therapies Inc.PRA Health Sciences; Tandem Labs; Xceleron IncCompletedN/A, as Healthy VolunteersNetherlands
-
Merz Pharmaceuticals GmbHCompletedN/A, as no Specific Medical Condition Will be TreatedGermany
-
Centre Hospitalier Sud FrancilienCompletedNo Condition : to Establish Reference Serum Serotonin Levels in a Control CohortFrance
-
Rebiscan, Inc.BlueGrass Orthopaedics Surgery & Hand CareCompletedWave Form Signals Coming From the Eye in a Healthy CohortUnited States
-
Cairo UniversityCompletedTo Investigate Influence of a Combined Interferential Current Stimulation and Abdominal Draw -in Exercises in Patients with Chronic NEgypt
Clinical Trials on PERCCS: Personalized Education Regarding Clinical and Community Supports
-
Instituto de Investigacion Sanitaria La FeSociedad Española de Neumología y Cirugía Torácica; Sociedad Valenciana de... and other collaboratorsRecruitingCommunity-acquired PneumoniaSpain
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Department of HealthCompletedColorectal CancerUnited States
-
Virginia Commonwealth UniversityAmerican Society of Health-System Pharmacists Research and Education FoundationRecruitingObesity | Kidney Transplant; ComplicationsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)Recruiting
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompleted
-
University of Michigan Rogel Cancer CenterThe Hope FoundationRecruitingMalignant Solid Neoplasm | Chemotherapy-Induced Peripheral Neuropathy | Hematopoietic and Lymphatic System NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Invasive Breast CarcinomaUnited States
-
Mayo ClinicEnrolling by invitationPancreatic CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterNot yet recruitingClinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage II Esophageal... and other conditionsUnited States
-
University of California, San FranciscoLazarex Cancer FoundationRecruitingProstate CarcinomaUnited States